Finland · Pre-seed startup

Who invested in Cornea Sense

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$1.3Mraised across 1 round since 2026, from 1 source

Latest round
Pre-seed, $1.3MJul 2026
Investors
2
See who backed them

The rounds

  1. Jul 2026
    Pre-seed$1.3M

    Source recorded

Founders and team

From Cornea Sense's own website: 1 founder, 1 on the team.

Samy MrenaEye surgeon, founder of multiple eye clinics
  • Mikko JuutiPhD Photonics, investment professional, one exit

Everyone who backed them

Business FinlandAccelerator1round
InnovestorAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cornea Sense as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Kinled HoldingPrivate equityPer its own site

Quick answers about Cornea Sense

Who invested in Cornea Sense?

Cornea Sense's investors include Business Finland and Innovestor.

How much has Cornea Sense raised?

Cornea Sense has raised $1.3M across 1 round since 2026.

When did Cornea Sense last raise?

Cornea Sense's most recent round was a Pre-seed of $1.3M in Jul 2026.

What was Cornea Sense's biggest round?

Its most recent round, $1.3M in Jul 2026, is also its largest on record.

Who backed Cornea Sense first?

Cornea Sense's first round on record, in Jul 2026, was backed by Business Finland and Innovestor.

What stage is Cornea Sense at?

Cornea Sense's latest named round is a Pre-seed, in Jul 2026.

Where is Cornea Sense based?

Cornea Sense is based in Finland.

Companies like Cornea Sense

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.